143 related articles for article (PubMed ID: 37777356)
1. Survival Differences of Patients with Resected Extraskeletal Osteosarcoma Receiving Two Different (Neo)Adjuvant Chemotherapy Regimens: A Systematic Review and Meta-analysis.
Campos F; Téres R; Sebio A; Bettim BB; Martinez-Trufero J
Clin Oncol (R Coll Radiol); 2023 Dec; 35(12):e720-e727. PubMed ID: 37777356
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implication of adjuvant/neoadjuvant chemotherapy consisting of doxorubicin and ifosfamide in patients with extraskeletal osteosarcoma.
Wakamatsu T; Kakunaga S; Takenaka S; Outani H; Hamada K; Imura Y; Hori Y; Naka N; Kudawara I; Yoshikawa H; Ueda T
Int J Clin Oncol; 2019 Oct; 24(10):1311-1319. PubMed ID: 31197555
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Adjuvant Chemotherapy on Localized Extraskeletal Osteosarcoma: A Systematic Review.
Tsukamoto S; Mavrogenis AF; Angelelli L; Righi A; Filardo G; Kido A; Honoki K; Tanaka Y; Tanaka Y; Errani C
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626164
[TBL] [Abstract][Full Text] [Related]
4. Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients.
Longhi A; Bielack SS; Grimer R; Whelan J; Windhager R; Leithner A; Gronchi A; Biau D; Jutte P; Krieg AH; Klenke FM; Grignani G; Donati DM; Capanna R; Casanova J; Gerrand C; Bisogno G; Hecker-Nolting S; De Lisa M; D'Ambrosio L; Willegger M; Scoccianti G; Ferrari S
Eur J Cancer; 2017 Mar; 74():9-16. PubMed ID: 28167373
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of multi-drug regimen chemotherapy treatment in osteosarcoma patients: a network meta-analysis of randomized controlled trials.
Wang X; Zheng H; Shou T; Tang C; Miao K; Wang P
J Orthop Surg Res; 2017 Mar; 12(1):52. PubMed ID: 28356114
[TBL] [Abstract][Full Text] [Related]
6. Extraskeletal Osteosarcoma: An International Rare Cancer Network Study.
Sio TT; Vu CC; Sohawon S; Van Houtte P; Thariat J; Novotny PJ; Miller RC; Bar-Sela G
Am J Clin Oncol; 2016 Feb; 39(1):32-6. PubMed ID: 24401667
[TBL] [Abstract][Full Text] [Related]
7. A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcoma.
Davis EJ; Chugh R; Zhao L; Lucas DR; Biermann JS; Zalupski MM; Feng M; Wong SL; Jacobson J; Zyczynski L; Reinke D; Metko G; Baker LH; Schuetze SM
Eur J Cancer; 2015 Sep; 51(13):1794-802. PubMed ID: 26066736
[TBL] [Abstract][Full Text] [Related]
8. Dose-intense ifosfamide/doxorubicin/cisplatin based chemotherapy for osteosarcoma in adults.
Patel SJ; Lynch JW; Johnson T; Carroll RR; Schumacher C; Spanier S; Scarborough M
Am J Clin Oncol; 2002 Oct; 25(5):489-95. PubMed ID: 12393991
[TBL] [Abstract][Full Text] [Related]
9. Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?
Fan Z; Patel S; Lewis VO; Guadagnolo BA; Lin PP
Clin Orthop Relat Res; 2015 Nov; 473(11):3604-11. PubMed ID: 26197952
[TBL] [Abstract][Full Text] [Related]
10. Treatment of non-metastatic high-grade osteosarcoma (study of 30 cases treated with Scandinavian osteosarcoma protocol XIV and surgery).
Samardziski M; Zafiroski G; Tolevska C; Zafirova-Ivanovska B; Kostadinova-Kunovska S; Kalicanin-Markovska M
Prilozi; 2008 Dec; 29(2):309-23. PubMed ID: 19259055
[TBL] [Abstract][Full Text] [Related]
11. Extraskeletal osteosarcoma of the breast in an adolescent girl.
Zils K; Ebner F; Ott M; Müller J; Baumhoer D; Greulich M; Rehnitz D; Rempen A; Schaetzle S; Wilhelm M; Bielack S
J Pediatr Hematol Oncol; 2012 Aug; 34(6):e261-3. PubMed ID: 22246152
[TBL] [Abstract][Full Text] [Related]
12. Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: does the analog matter?
Yu W; Tang L; Lin F; Yao Y; Shen Z
Med Oncol; 2015 Jan; 32(1):307. PubMed ID: 25432694
[TBL] [Abstract][Full Text] [Related]
13. A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma.
Schmitt T; Lehner B; Kasper B; Bischof M; Roeder F; Dietrich S; Dimitrakopoulou-Strauss A; Strauss LG; Mechtersheimer G; Wuchter P; Ho AD; Egerer G
BMC Cancer; 2011 Dec; 11():510. PubMed ID: 22152120
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy for pediatric osteosarcoma patients.
Uchida A; Myoui A; Araki N; Yoshikawa H; Shinto Y; Ueda T
Cancer; 1997 Jan; 79(2):411-5. PubMed ID: 9010116
[TBL] [Abstract][Full Text] [Related]
15. Limb-sparing in patients with non-metastatic high-grade osteosarcoma.
Samardziski M; Zafiroski G; Tolevska C; Zafirova-Ivanovska B; Kostadinova-Kunovska S; Kalicanin-Markovska M
J BUON; 2009; 14(1):63-9. PubMed ID: 19373949
[TBL] [Abstract][Full Text] [Related]
16. The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma.
Heng M; Gupta A; Chung PW; Healey JH; Vaynrub M; Rose PS; Houdek MT; Lin PP; Bishop AJ; Hornicek FJ; Chen YL; Lozano-Calderon S; Holt GE; Han I; Biau D; Niu X; Bernthal NM; Ferguson PC; Wunder JS; ;
Eur J Cancer; 2020 Jan; 125():130-141. PubMed ID: 31806415
[TBL] [Abstract][Full Text] [Related]
17. Single institution retrospective review of perioperative chemotherapy in adult and adolescent patients with operable osteosarcoma.
Hansen AR; Hughes BG; Paul S; Steadman P; Sommerville S; Dickinson IC; Walpole ET; Thomson DB; Mar Fan HG; Joubert WL
Asia Pac J Clin Oncol; 2016 Jun; 12(2):e222-8. PubMed ID: 24571381
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant and neoadjuvant chemotherapy for osteosarcoma: JCOG Bone and Soft Tissue Tumor Study Group.
Hiraga H; Ozaki T
Jpn J Clin Oncol; 2021 Oct; 51(10):1493-1497. PubMed ID: 34322695
[TBL] [Abstract][Full Text] [Related]
19. Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial.
Piperno-Neumann S; Le Deley MC; Rédini F; Pacquement H; Marec-Bérard P; Petit P; Brisse H; Lervat C; Gentet JC; Entz-Werlé N; Italiano A; Corradini N; Bompas E; Penel N; Tabone MD; Gomez-Brouchet A; Guinebretière JM; Mascard E; Gouin F; Chevance A; Bonnet N; Blay JY; Brugières L; ; ;
Lancet Oncol; 2016 Aug; 17(8):1070-1080. PubMed ID: 27324280
[TBL] [Abstract][Full Text] [Related]
20. Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.
Lewis IJ; Nooij MA; Whelan J; Sydes MR; Grimer R; Hogendoorn PC; Memon MA; Weeden S; Uscinska BM; van Glabbeke M; Kirkpatrick A; Hauben EI; Craft AW; Taminiau AH; ;
J Natl Cancer Inst; 2007 Jan; 99(2):112-28. PubMed ID: 17227995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
